Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practice.

de Bie MK, Thijssen J, van Rees JB, Putter H, van der Velde ET, Schalij MJ, van Erven L.

Heart. 2013 Jul;99(14):1018-23. doi: 10.1136/heartjnl-2012-303349. Epub 2013 May 23.

PMID:
23704324
[PubMed - indexed for MEDLINE]
2.

The mode of death in implantable cardioverter-defibrillator and cardiac resynchronization therapy with defibrillator patients: results from routine clinical practice.

Thijssen J, van Rees JB, Venlet J, Borleffs CJ, Höke U, Putter H, van der Velde ET, van Erven L, Schalij MJ.

Heart Rhythm. 2012 Oct;9(10):1605-12. doi: 10.1016/j.hrthm.2012.04.021. Epub 2012 Apr 20.

PMID:
22522066
[PubMed - indexed for MEDLINE]
3.

Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score.

van Rees JB, Borleffs CJ, van Welsenes GH, van der Velde ET, Bax JJ, van Erven L, Putter H, van der Bom JG, Schalij MJ.

Heart. 2012 Jun;98(11):872-7. doi: 10.1136/heartjnl-2011-300632.

PMID:
22581736
[PubMed - indexed for MEDLINE]
4.

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA 3rd, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P.

JAMA. 2007 Jul 25;298(4):405-12. Erratum in: JAMA. 2007 Oct 3;298(13):1516.

PMID:
17652294
[PubMed - indexed for MEDLINE]
5.

Application of a mortality risk score in a general population of patients with an implantable cardioverter defibrillator (ICD).

Schaer BA, Kühne MS, Blatter D, Osswald S, Sticherling C.

Heart. 2014 Mar;100(6):487-91. doi: 10.1136/heartjnl-2013-305002. Epub 2014 Jan 10.

PMID:
24415667
[PubMed - indexed for MEDLINE]
6.

Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(11):1099-110.

PMID:
23180517
[PubMed - indexed for MEDLINE]
7.

Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.

Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.

Kardiol Pol. 2012;70(12):1264-75.

PMID:
23264245
[PubMed - indexed for MEDLINE]
8.

Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.

Martinelli M, de Siqueira SF, Sternick EB, Rassi A Jr, Costa R, Ramires JA, Kalil Filho R.

Am J Cardiol. 2012 Oct 1;110(7):1040-5. doi: 10.1016/j.amjcard.2012.05.040. Epub 2012 Jun 20.

PMID:
22727179
[PubMed - indexed for MEDLINE]
9.

Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.

Kron J, Sauer W, Schuller J, Bogun F, Crawford T, Sarsam S, Rosenfeld L, Mitiku TY, Cooper JM, Mehta D, Greenspon AJ, Ortman M, Delurgio DB, Valadri R, Narasimhan C, Swapna N, Singh JP, Danik S, Markowitz SM, Almquist AK, Krahn AD, Wolfe LG, Feinstein S, Ellenbogen KA.

Europace. 2013 Mar;15(3):347-54. doi: 10.1093/europace/eus316. Epub 2012 Sep 21.

PMID:
23002195
[PubMed - indexed for MEDLINE]
Free Article
10.

Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators.

Tandri H, Griffith LS, Tang T, Nasir K, Zardkoohi O, Reddy CV, Capps M, Calkins H, Donahue JK.

Heart Rhythm. 2006 Jul;3(7):762-8. Epub 2006 Mar 27.

PMID:
16818202
[PubMed - indexed for MEDLINE]
11.

The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE.

J Am Coll Cardiol. 2012 Nov 6;60(19):1933-9. doi: 10.1016/j.jacc.2012.06.053. Epub 2012 Oct 10.

PMID:
23062537
[PubMed - indexed for MEDLINE]
Free Article
12.

Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience.

Aydin A, Hartel F, Schlüter M, Butter C, Köbe J, Seifert M, Gosau N, Hoffmann B, Hoffmann M, Vettorazzi E, Wilke I, Wegscheider K, Reichenspurner H, Eckardt L, Steven D, Willems S.

Circ Arrhythm Electrophysiol. 2012 Oct;5(5):913-9. doi: 10.1161/CIRCEP.112.973339. Epub 2012 Aug 23.

PMID:
22923274
[PubMed - indexed for MEDLINE]
Free Article
13.

[The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].

Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.

Rev Esp Cardiol. 2006 Jun;59(6):537-44. Spanish.

PMID:
16790196
[PubMed - indexed for MEDLINE]
Free Article
14.

[Indications for an implantable cardioverter/defibrillator].

Schwab JO, Lüderitz B.

Internist (Berl). 2007 Jul;48(7):715-23; quiz 724-5. German.

PMID:
17541533
[PubMed - indexed for MEDLINE]
15.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

PMID:
19506335
[PubMed - indexed for MEDLINE]
Free Article
16.

Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy.

Grimm W, Flores BT, Marchlinski FE.

Circulation. 1993 Jun;87(6):1880-8.

PMID:
8504500
[PubMed - indexed for MEDLINE]
17.

Sudden death in recipients of transvenous implantable cardioverter defibrillator systems: terminal events, predictors, and potential mechanisms.

Pires LA, Hull ML, Nino CL, May LM, Ganji JR.

J Cardiovasc Electrophysiol. 1999 Aug;10(8):1049-56.

PMID:
10466484
[PubMed - indexed for MEDLINE]
18.

Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.

Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH; ALPHEE Study Investigators.

Circulation. 2011 Dec 13;124(24):2649-60. doi: 10.1161/CIRCULATIONAHA.111.072561. Epub 2011 Nov 14.

PMID:
22082672
[PubMed - indexed for MEDLINE]
Free Article
19.

Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.

Hua W, Niu H, Fan X, Ding L, Xu YZ, Wang J, Chen K, Wang F, Zhang S; ICD Study Group.

J Cardiovasc Electrophysiol. 2012 Nov;23 Suppl 1:S5-9. doi: 10.1111/j.1540-8167.2012.02435.x.

PMID:
23140347
[PubMed - indexed for MEDLINE]
20.

Appropriate therapy but not inappropriate shocks predict survival in implantable cardioverter defibrillator patients.

Dichtl W, Wolber T, Paoli U, Brüllmann S, Stühlinger M, Berger T, Spuller K, Strasak A, Pachinger O, Haegeli LM, Duru F, Hintringer F.

Clin Cardiol. 2011 Jul;34(7):433-6. doi: 10.1002/clc.20910. Epub 2011 Jun 15.

PMID:
21678454
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk